Northbank Communications joins College Hill
Northbank Communications announces that it has entered into an agreement to become part of College Hill, the international business communications consultancy, by way of 100% acquisition of the shares in Northbank Communications by College Hill.
According to the company, Northbank has built a strong reputation and global client base in the life science sector, with clients including Ablynx, Biota, BTG, Cambridge Antibody Technology (AZ), Ganymed, GE Healthcare, LifeCycle Pharma, Midatech, Nautilus Biotech, Nitec Pharma, Novozymes, Oxford BioMedica, Perkin Elmer, Santaris Pharma, Sigma-Aldrich and Smiths Detection. It offers services across corporate, financial and marketing communications, including an in-house design studio. The deal substantially strengthens Northbank's offering in financial communications, and adds new areas of expertise for its clients through College Hill's Public Policy, Internal Engagement and Strategic Research practices. The international reach of College Hill also enhances Northbank's global capability, through offices in Hong Kong and Johannesburg.
Following the acquisition, which was brokered by corporate finance advisory firm Pembridge Partners LLP, College Hill will retain Northbank's current structure and facilities, including its team of 32 across offices in London, Manchester and Munich. Sue Charles, CEO of Northbank will head College Hill's Life Sciences industry team and will become Managing Partner, Life Sciences. Northbank senior team members Katja Stout, Director and Chris Fisher, Creative Director will be appointed as Partner and Associate Partner/Creative Director, Life Sciences respectively. Co-founder and Director of Northbank, Peter Colley will retire at the year end. Northbank's venture investors, Pembridge Partners exit as part of the deal.
Other news from the department business & finance
